Related Experiment Video
Updated: Feb 3, 2026

Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease
Published on: April 19, 2015
Cytomegalovirus Retinitis in Primary Immune Deficiency Disease
Jia Jeane Ngai1, Ka Lung Chong1, Shelina Oli Mohamed2
1Department of Ophthalmology, Hospital Bintulu, Sarawak, Malaysia.
Introduction:
To report an unusual case of CMV retinitis in Primary Immune Deficiency Disease (PIDD).
Case Report:
13-year-old child with combined T and B cell deficiencies was diagnosed of bilateral zone 1 CMV retinitis. Intravitreal injections were unable to be given in a regular and timely manner under general anaesthesia due to her underlying systemic disease. The child was treated with intravenous ganciclovir for 8 weeks until eventual resolution of the retinitis. However, visual acuity deteriorated due to progressive optic nerve involvement.
Conclusion:
Paediatric patients often do not notice subtle symptoms of CMV retinitis. Although ocular manifestations are uncommon in PIDD, recognition and high index of suspicion will allow for timely referral, diagnosis, and treatment to be instituted for better visual outcomes.
Related Concept Videos
What is the Immune System?
Humoral Immune Responses
Primary Active Transport
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Introduction to Lymphatic and Immune System
The immune responses can be categorized into two types: innate and adaptive. Innate immunity comprises nonspecific defenses we are...

